非尿毒症性钙化防御患者的人口统计学、合并症和结局。
Demographics, Comorbid Conditions, and Outcomes of Patients With Nonuremic Calciphylaxis.
机构信息
Division of Dermatology, Department of Medicine, University of Washington, Seattle.
出版信息
JAMA Dermatol. 2019 Feb 1;155(2):251-252. doi: 10.1001/jamadermatol.2018.4937.
Abstract
This study analyzes medical records of patients with nonuremic calciphylaxis from the University of Washington Hospital System to evaluate demographic characteristics, comorbid conditions, and outcomes.
摘要
本研究分析了来自华盛顿大学医院系统的非尿毒症性钙化防御患者的病历，以评估人口统计学特征、合并症和结局。
相似文献
1
Demographics, Comorbid Conditions, and Outcomes of Patients With Nonuremic Calciphylaxis.非尿毒症性钙化防御患者的人口统计学、合并症和结局。
JAMA Dermatol. 2019 Feb 1;155(2):251-252. doi: 10.1001/jamadermatol.2018.4937.
2
Low-dose tissue plasminogen activator for calciphylaxis.低剂量组织型纤溶酶原激活剂用于钙化防御。
Arch Dermatol. 2004 Sep;140(9):1045-8. doi: 10.1001/archderm.140.9.1045.
3
Use of sodium thiosulfate in the treatment of calciphylaxis.硫代硫酸钠在钙化防御治疗中的应用。
Saudi J Kidney Dis Transpl. 2009 Nov;20(6):1065-8.
4
Successful treatment of calciphylaxis with intravenous sodium thiosulfate in a nonuremic patient: case report and review of therapy side effects.非尿毒症患者静脉注射硫代硫酸钠成功治疗钙化防御：病例报告及治疗副作用综述
J Cutan Med Surg. 2014 Oct;18(5):356-60. doi: 10.2310/7750.2013.13117.
5
Calciphylaxis from nonuremic causes: a systematic review.非尿毒症病因所致的钙过敏症：一项系统综述
Clin J Am Soc Nephrol. 2008 Jul;3(4):1139-43. doi: 10.2215/CJN.00530108. Epub 2008 Apr 16.
6
The Signs Aligned: Nonuremic Calciphylaxis.症状相符：非尿毒症性钙化防御。
Am J Med. 2017 Sep;130(9):1051-1054. doi: 10.1016/j.amjmed.2017.05.006. Epub 2017 Jun 8.
7
Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate.长期静脉注射硫代硫酸钠使复发性钙化防御完全消退。
Australas J Dermatol. 2008 Feb;49(1):30-4. doi: 10.1111/j.1440-0960.2007.00416.x.
8
Successful treatment of calciphylaxis with intravenous sodium thiosulfate.静脉注射硫代硫酸钠成功治疗钙过敏症。
Am J Kidney Dis. 2004 Jun;43(6):1104-8. doi: 10.1053/j.ajkd.2004.03.018.
9
Widespread calciphylaxis and normal renal function: no improvement with sodium thiosulfate.广泛的钙化防御与正常肾功能：硫代硫酸钠治疗无效
Dermatol Online J. 2015 May 18;21(5):13030/qt76845802.
10
Successful treatment of non-uremic calciphylaxis with combination therapy with sodium thiosulfate, iloprost, and heparin.硫代硫酸钠、伊洛前列素和肝素联合治疗非尿毒症性钙化防御取得成功。
Int J Dermatol. 2024 Jul;63(7):962-963. doi: 10.1111/ijd.17131. Epub 2024 Mar 20.
引用本文的文献
1
Calciphylaxis: ongoing challenges and treatment opportunities with mesenchymal stem cells.钙过敏：间充质干细胞面临的持续挑战与治疗机遇
J Mol Cell Biol. 2025 Jul 28;17(2). doi: 10.1093/jmcb/mjaf009.
2
Outcomes in an educational skin-model session on point-of-care ultrasound for diagnosing calciphylaxis.关于即时超声诊断钙过敏的教育性皮肤模型课程的结果
Skin Health Dis. 2024 Oct 28;4(6):e467. doi: 10.1002/ski2.467. eCollection 2024 Dec.
3
Cardiodermatology: the heart of the connection between the skin and cardiovascular disease.心脏皮肤医学：皮肤与心血管疾病关联的核心
Nat Rev Cardiol. 2025 May;22(5):354-371. doi: 10.1038/s41569-024-01097-9. Epub 2024 Nov 13.
4
Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report.模仿巨细胞动脉炎的钙化防御：一例报告
Case Rep Ophthalmol. 2024 Oct 4;15(1):717-723. doi: 10.1159/000541410. eCollection 2024 Jan-Dec.
5
Calciphylaxis in a patient with hypoparathyroidism and MEN-1 syndrome.一名甲状旁腺功能减退症和多发性内分泌腺瘤1型综合征患者的钙过敏症。
Endocrinol Diabetes Metab Case Rep. 2023 Dec 8;2023(4). doi: 10.1530/EDM-23-0009. Print 2023 Oct 1.
6
Calcific Uremic Arteriolopathy in End-Stage Renal Disease: A Rare Life-Threatening Condition.终末期肾病中的钙化性尿毒症小动脉病：一种罕见的危及生命的病症。
Cureus. 2023 Oct 30;15(10):e48002. doi: 10.7759/cureus.48002. eCollection 2023 Oct.
7
Uremic Bilateral Breast Calciphylaxis: A Case Report and Literature Review.尿毒症双侧乳腺钙化防御：一例报告及文献综述
Cureus. 2023 Sep 26;15(9):e46024. doi: 10.7759/cureus.46024. eCollection 2023 Sep.
8
Nonuremic calciphylaxis manifesting with diffuse dermal angiomatosis.表现为弥漫性皮肤血管瘤病的非尿毒症性钙化防御。
JAAD Case Rep. 2022 Apr 4;24:8-10. doi: 10.1016/j.jdcr.2022.03.029. eCollection 2022 Jun.
9
Atypical presentation of nonuremic calciphylaxis in a female patient with metastatic breast cancer.一名转移性乳腺癌女性患者的非尿毒症性钙化防御的非典型表现。
Int J Womens Dermatol. 2020 Dec 21;7(3):363-364. doi: 10.1016/j.ijwd.2020.12.009. eCollection 2021 Jun.
本文引用的文献
1
Calciphylaxis.钙过敏症
N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292.
2
Calciphylaxis from nonuremic causes: a systematic review.非尿毒症病因所致的钙过敏症：一项系统综述
Clin J Am Soc Nephrol. 2008 Jul;3(4):1139-43. doi: 10.2215/CJN.00530108. Epub 2008 Apr 16.
3
Calciphylaxis: natural history, risk factor analysis, and outcome.钙过敏症：自然病史、危险因素分析及预后
J Am Acad Dermatol. 2007 Apr;56(4):569-79. doi: 10.1016/j.jaad.2006.08.065. Epub 2006 Dec 1.
4
Musculoskeletal manifestations of chronic renal failure.慢性肾衰竭的肌肉骨骼表现
Curr Opin Rheumatol. 2003 Jan;15(1):48-54. doi: 10.1097/00002281-200301000-00009.
5
Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy.钙过敏通常无溃疡形成：危险因素、结局及治疗
Kidney Int. 2002 Jun;61(6):2210-7. doi: 10.1046/j.1523-1755.2002.00375.x.
Zotero 插件